Polycystic kidney disease is characterized by abnormal morphological development. Mechanisms that regulate cyst development may involve multiple signaling pathways. Cyst formation by Madin-Darby canine kidney (MDCK) cells in three-dimensional culture is assumed to be cyclic AMP-dependent and due to cyclic AMP-dependent protein kinase (cAPK) activation based on pharmacological responsiveness. To determine if different cyclic AMP (cAMP) pathways are associated with morphological development, the role of cAMP in regulating morphological change was examined in MDCK clones that form tumor-like or tubular structures under basal conditions. Pharmacological cAMP pathway activators induce cyst formation and diminish formation of other structures in three clones, whereas one clone is unaffected. Tyrosine kinase-mediated morphogens have little effect. Although all clones have intact cAMP signaling pathways, each has a unique subcellular distribution of cAPK regulatory subunits. This may reflect distinct mechanisms for cAPK anchoring, allowing cAPK subtype regulation of the unique phenotypic character of each clone through preferential access to substrates. These observations suggest a molecular basis for differential cAMP responsiveness in cells that develop distinct morphological phenotypes. This evidence establishes these MDCK clones as models for understanding the mechanism and functional significance of cAPK subunit localization and may have broader implications for cystogenesis in polycystic kidney disease.
Madin-Darby canine kidney cells (3) are a renal epithelial cell line whose collecting tubule-like cells have been used to characterize renal transport physiology, to study polarized sorting of epithelial cell membrane proteins, and to study morphogenesis. The range of phenotypic variety observed in MDCK 1 cells is now accepted as the result of both cellular heterogeneity and some cellular multipotence (Refs. 4 -7 and comments associated with Ref. 8) . In three-dimensional collagen gel culture, MDCK cells can form spherical cysts by clonal growth (9) , can be induced to enlarge after stimulation with cAMP analogues (10 -12) , and can form branching tubules in response to HGF (13, 14) . Many more reports have implicated tyrosine kinases, phosphoinositide metabolism, and ␤-catenins in tubule formation and branching morphogenesis (14 -19) . Although cellular mechanisms for tubule formation have been addressed in detail, reports addressing MDCK cyst formation have used pharmacological responsiveness to activators and inhibitors of cAMP pathway components to demonstrate cAMP-dependence (Refs. 6, 10 -12, 14, and 20 and reviewed in Ref. 7) . Several reports have addressed the role of the cAMP pathway in MDCK cell proliferation and chloride and fluid transport (10, 11, (21) (22) (23) (24) (25) . None of these studies have fully addressed links between cAMP, the specific effector of cAMP action, and cystogenesis.
The cAMP-dependent protein kinase is the primary cellular mediator of cAMP action and is a holoenzyme composed of four subunits: two regulatory (R) and two catalytic (C). The binding of two cAMP molecules to each R subunit promotes the release of C subunits, which then phosphorylate substrate proteins on serine residues. Both R and C subunits exist as multiple isoforms that probably contribute to the range of cellular functions attributed to cAMP, including modulation of enzyme activity, membrane channel activity, and gene expression (reviewed in Refs. 26 and 27) . In addition to diversity generated by subunit isoforms, cAPK can be localized to specific intracellular locations by A-kinase anchoring proteins (AKAPs) (reviewed in Ref. 28) , thus allowing cAPK action to be directed to discrete subcellular sites and targets (29, 30) . Nuclear C subunits translocated from the cytoplasm to regulate gene expression are inhibited and shuttled back out by the endogenous cAPK inhibitor, PKI (protein kinase inhibitor) (31) (32) (33) (34) (35) (36) (37) . Kinase activity is turned off in the cytoplasm as cellular cAMP levels decline and cAPK holoenzyme is reformed.
Observations from studies of four novel MDCK cell clones isolated from original American Type Culture Collection MDCK CCL-34 (6) support the suggestion that induction of intracellular cAMP formation negatively regulates tubular structure formation in certain clones and implies that cystogenesis may represent a "default pathway" for impaired tubulogenesis. It is possible that cross-talk between signaling pathways, specific target substrates, and/or variable expression of pathway component isoforms may regulate the appearance of morphological phenotypes in different cell types. Therefore, the focus of this study is the role of cAPK in mediating both cyst formation and the inhibition of tubule formation. The present study uses the four previously described MDCK clones (6) as tools to understand the molecular mechanism for cAMP regulation of MDCK morphology. Pharmacological, biochemical, microscopic, and molecular genetic techniques were used to examine cAPK in these clones. Differences in cAPK components were found that may be important for in vitro cyst formation and for inhibition of tubule formation.
EXPERIMENTAL PROCEDURES
Cell Culture-Stocks of MDCK cell clones (clone OR93.22.D6 is designated 22 in this report, OR55.25.II20 is designated 25, OR55.28.V2 is designated 28, and OR55.29 is designated 29) were cultured as described previously (6) . Cells in three-dimensional Vitrogen-100® (Cohesion, Palo Alto, CA) gels were cultured in defined medium (6) with experimental changes noted in the figure legends. Quantitation of structure formation after 5-9 days of gel culture was performed as described previously (6) . Briefly, for each sample, the incidence of specific cellular structures (process-forming, cystic, and tumor-like) was scored relative to the total number of structures observed in the sample. Process formation is a predictor of tubule formation, cystic structures have defined cyst walls and open interior lumens, and dense cell spheres or cysts with wall thicknesses greater than the diameter of a lumen are designated "tumor-like." MDCK cells used for intracellular cAMP determinations, cAMP-dependent protein kinase assays, reporter gene assays, Western analysis of protein expression, and immunofluorescence studies were seeded in 0.4-m pore Transwell-Clear filter inserts (Corning Costar Corp., Cambridge, MA) at approximately 1800 cells/cm 2 . Under these conditions, cells formed confluent monolayers by 1 week in culture. Although time frames for experimental determinations in filter culture were not the same as for three-dimensional structure formation in gel culture, intact epithelial layers had been established before assay or treatment in all cases, as demonstrated by transepithelial resistance measurements (6) . All filter-grown cultures were maintained in serum-containing Dulbecco's modified Eagle's medium/F-12 (1:1, Life Technologies Inc.) until used for experiments, when growth medium was replaced with defined medium lacking PGE 1 (6) . All growth and experimental incubations of live cell cultures took place in a tissue culture incubator with a humidified 37°C atmosphere of 5% CO 2 , 95% air.
Intracellular cAMP Determinations-Cells were seeded onto 12-mm diameter Transwell-Clear inserts (Corning Costar Corp.) and maintained in culture as described above. Growth medium was removed, and confluent cell monolayers were washed 3ϫ with PBS (10 mM Na 3 PO 4 , 150 mM NaCl, pH 6.9). Defined medium with additions indicated in the figure legends was added, and cultures were again placed in the tissue culture incubator for 1 h. Monolayers were then placed on ice, washed 3ϫ with PBS, prepared for intracellular cAMP determinations using the cell lysis and assay reagents from the BIOTRAK cAMP enzyme immunoassay kit (RPN225, Amersham Life Science), and assayed according to the manufacturer's protocol. Values were normalized for protein content.
Cyclic AMP-dependent Protein Kinase Assays-Cells were seeded onto 24-mm diameter Transwell-Clear inserts (Corning Costar Corp.) and maintained in culture as described above. Samples were prepared for assay as described (38) . Cyclic AMP-dependent protein kinase activity was measured using the Colorimetric PKA SpinZyme™ Format assay kit (29500, Pierce) in the presence or absence of cAMP. The difference between the two values reflects cAMP-dependent activity. In the present study, activity in the absence of cAMP was negligible. The assay, conducted according to the manufacturer's protocol, detects the incorporation of phosphate into a specific dye-labeled cAPK substrate, Leu-Arg-Arg-Ala-Ser-Leu-Gly (Kemptide). Purified C subunit from bovine heart (Pierce) was used to generate a standard activity curve. All sample values were normalized for protein content.
Reporter Gene Assay-To measure the ability of each clone to induce cAMP-mediated gene expression, all clones were transiently co-transfected with expression vectors encoding luciferase and ␤-galactosidase cDNAs, as described previously (39) . Luciferase cDNA is under the control of a promoter that confers sensitivity to activation of cAPK (40) , whereas the ␤-galactosidase cDNA is under the control of a constitutive promoter. Confluent Transwell-Clear filter cultures of MDCK clones were transfected with cDNA and LipofectAMINE™ (Life Technologies, Inc.). Mixtures of LipofectAMINE™ (2.7 g/12 mm insert), ␣-168-luciferase cDNA (91 g/12-mm insert), and Rous sarcoma virus-␤-galactosidase cDNA (91 g/12-mm insert) were prepared according to the manufacturer's protocol in Dulbecco's modified Eagle's medium/F-12 (1:1) medium. Lipid/cDNA mixtures were left on the cells for 24 h. Medium was removed and replaced with defined medium plus additions indicated in Fig. 4 for 6 h. Cell lysates were harvested as described previously (39) Western Analysis of Protein Expression-To characterize protein expression in cultured cells, samples grown on filter inserts were harvested, subjected to SDS-polyacrylamide gel electrophoresis, immunoblotting, and signal detection with ECL™ (Amersham Pharmacia Biotech) essentially as described previously (41) . Protein loaded in each lane was equal for all clones (10 g). Primary antibodies used (listed above) were: anti-C␣ sc-903 at 1:1000; anti-RI P19920 at 1:100 -250 and P53620 at 1:100; and anti-RII␣ sc-909 at 1:250 -500 and P55120 at 1:250. Peroxidase-linked secondary antibodies were used at 1:1000 -10,000 dilutions. Specific primary and secondary antibody combinations are indicated in the figure legends. Densities of the resulting specific bands shown in Fig. 5 were measured with a Sci Scan 5000 densitometer using the OS-Scan Image Analysis System 0306-371-10001 Release 4.2 (Oberlin Scientific Corp., Oberlin, OH) of the Molecular Biology Core Laboratory at Case Western Reserve University. Sample values are expressed as arbitrary units relative to the value resulting from the least dense band (set to 1 unit) in each subunit group.
Localization Studies-Confocal laser scanning microscopy was used to localize specific proteins identified by immunofluorescence. Cells were seeded onto 12-mm-diameter Transwell-Clear inserts and maintained in culture as described above. Primary antibodies (listed above) used were anti-C␣ P73420, anti-RI P19920, and anti-RII␣ P55120. Nonspecific binding sites were blocked, as described below, with normal serum from the host animal used to raise the secondary antibody, in this case, GS (Sigma). The secondary antibody O-6380, with a fluorescent tag, used is listed above. The specificity of antibody immunoreactivity was demonstrated using controls lacking primary antibodies, which in all cases resulted in no detectable fluorescent signal (data not shown).
All steps were performed at room temperature unless noted and are essentially as described previously (42) . Similar methods have been used to visualize cytoskeletal and tight junction proteins in confluent MDCK filter cultures (43, 44) . Insert cultures were fixed with 3.7% paraformaldehyde in PBS for 10 min. Surfaces were washed 3ϫ with PBS for 5 min each. Monolayers were permeabilized from the apical surface with 0.1% Triton X-100 in PBS for 5 min. Both surfaces were then washed 2ϫ with FBS/PBS (10% FBS in PBS) and then with GS/PBS (10% GS in PBS). The apical GS/PBS wash was removed and replaced with primary antibody diluted 1:100 in GS/PBS. After a 1-h incubation in the 37°C humidified incubator, samples were washed 3ϫ with FBS/PBS. The last FBS/PBS wash was removed from the apical surface and replaced with the appropriate secondary antibody diluted 1:250 in GS/PBS. After a 30-min incubation at 37°C, surfaces were washed 2ϫ in FBS/PBS and then in PBS. The Transwell-Clear membrane was cut out and mounted on a standard glass microscope slide with SlowFade™ Antifade kit component A (Molecular Probes).
All samples were examined, as described previously (42), with a Zeiss LSM 410 scanning laser confocal microscope using the 488/568-nm wavelength lines of an argon-krypton laser. Using a Zeiss 100ϫ Neofluor objective and Zeiss LSM software, the cell monolayer was optically sectioned every 0.5 m. Image resolution was 512 ϫ 512 pixels.
Other Information-Statistical determinations are indicated in the figure legends. Protein was quantitated using either the Bio-Rad or BCA (Pierce) protein assay reagents, according to the manufacturer's protocol. Reagents not specifically listed above were either cell culture or molecular biology grade and were obtained from Sigma, CalbiochemNovachem Corp., Life Technologies, Inc., or R&D Systems Inc. (Minneapolis, MN)
RESULTS

Clonal Differences Were Observed in Morphological
Responsiveness to cAMP Pathway Agonists-In our previous report (6), Vitrogen-100® gel cultures of MDCK clones 22, 28, and 29 formed tumor-like structures in the absence of cAMP agonists, and clone 25 formed tubular structures. All 4 clones had similar transepithelial resistances, but only clone 29 formed domes in monolayer culture (6) . To examine the role of cAMP-signaling system components in regulating clonal cyst and tubule formation, gel cultures of each clone were overlaid with defined medium lacking PGE 1 . Cultures were then incubated with pharmacological agents targeted to cell surface receptors (PGE 1 , arginine-8-vasopressin, isoproterenol), heterotrimeric GTP-binding protein G␣ s (cholera toxin), adenylyl cyclase (forskolin), cAMP phosphodiesterase (IBMX), or cAPK (cell-permeable cAMP analog 8BrcAMP), and the formation of specific structures was scored as described under "Experimental Procedures." The phosphodiesterase inhibitor IBMX had little effect on structure formation at 100 M and was included in all other conditions to block the breakdown of intracellular cAMP generated by specific agonists (Fig. 1) (11) . As described previously (6) and shown here as a positive control (Fig. 1) , increasing concentrations of PGE 1 resulted in cyst formation in all clones except clone 28, which formed spontaneous tumor-like structures and was previously shown to be incapable of PGE 1 -mediated cyst formation. Neither vasopressin nor isoproterenol had any effect on cyst formation in these clones (data not shown), unlike previously described MDCK clonal cell lines (reviewed in Ref. 7) . Cholera toxin, forskolin, and cyclic 8-bromo-adenosine 3Ј,5Ј-monophosphate 8BrcAMP effects were similar to those of PGE 1 (Fig. 1) . These agents also decreased the formation of processes (clone 25) and tumor-like structures (clones 22 and 29) in responsive clones that expressed these phenotypes but had no effect on clone 28. Doses required for stimulation of cyst formation and loss of original phenotype were nearly identical within each responsive clone and were similar between clones (Fig. 1) . Also, the order of effectiveness was the same for all responsive clones. Therefore, activation of the cAMP pathway at several levels resulted in cyst formation and loss of the original phenotype of the clone in all clones except clone 28.
Clonal Differences in cAMP Responsiveness Were Not Due to Lack of cAMP Pathway Components or Ability to Activate cAMP-mediated Gene Expression-To determine if the clone 28
lack of responsiveness to cyst-promoting agonists was the result of missing or defective cAMP pathway components, intracellular cAMP accumulation in response to agonists was measured in clones grown on filter insert cultures. As shown in Fig.  2 , all clones had similar basal levels of cAMP. All clones showed increases in intracellular cAMP levels in response to PGE 1 and forskolin, although the magnitude of the responses differed. Clones 22, 25, and 28 responded to PGE 1 or forskolin with cAMP levels between 2.5-7.4-fold greater than with IBMX alone. In general, clone 29 was less responsive; cAMP accumulation in response to forskolin was1.8-fold greater than IBMX alone and in response to PGE 1 was 1.5-fold greater than IBMX alone. Clone 25 displayed the greatest difference in cAMP levels produced in response to the two stimuli. Nevertheless, these results support the conclusion that coupling of receptor, GTP-binding proteins, and adenylyl cyclase in each clone was intact and that the inability of clone 28 to form cysts was not the result of an inability to elevate intracellular cAMP levels.
To determine if the lack of responsiveness of clone 28 to cyst-promoting agonists was the result of missing or defective cAPK, total cAPK activity was measured in clones grown on filter insert cultures. While the activity assay does not distinguish between Type I and Type II subtypes, as shown in Fig. 3 all clones had measurable cAMP-dependent cAPK activity. No cAMP-independent, basal activity was detected in any clone. Therefore, the inability of clone 28 to form cysts was not the result of a lack of cAPK activity, although clonal differences were observed in overall activity levels.
Since one of the results of cAMP pathway activation is regulation of cAMP-inducible genes, differences in the capacity of the four clones to induce cAMP-mediated gene expression were evaluated. Confluent clones grown on filter inserts were tran- 
cAPK Subunit Localization in MDCK Clones
siently transfected with a cAMP-responsive luciferase reporter gene as described under "Experimental Procedures." After a 6-h incubation with PGE 1 or forskolin, agonists that induce intracellular elevations of cAMP and presumably activate cAPK in all clones (Figs. 2 and 3) , induction of reporter activity was measured. All clones showed some amount of increased gene expression in response to the cAMP phosphodiesterase inhibitor, IBMX (Fig. 4) . Interestingly, clone 28 had severalfold higher levels of reporter activity than the 3 clones that responded to agonists with cyst formation. Clone 25 showed the largest PGE 1 -mediated induction of gene expression over IBMX alone, compared with other clones that showed minimal increases. Consistent with the difference observed in cAMP accumulation, forskolin did not produce a gene expression response in clone 25. Clone 29, the clone able to form the largest cysts, displayed little PGE 1 or forskolin-stimulated gene expression greater than with IBMX alone. However, all clones were capable of some level of reporter gene expression.
Clonal Differences in cAPK Subunit Localization Were Observed-The results of experiments to characterize intracellular cAMP signal transduction and the expression of specific clonal phenotypes in gel culture suggested differences could occur at the level of the cAPK or beyond. Therefore, expression and localization of the most widely expressed cAPK subunit isoforms RI␣, RII␣, and C␣ were determined (reviewed in Ref. 27 ). All clones expressed cAPK subunit proteins RI␣, RII␣, and C␣, as shown by the results of Western analyses of confluent Transwell cultures (Fig. 5) . Relative expression levels for RII␣ were 1.9, 2.2, 1.0, and 2.0 arbitrary units for clones 22, 25, 28, and 29, respectively. Relative expression levels for RI␣ were 1.4, 1.7, 1.0, and 2.3 units. Relatively greater expression of C␣ was detected in samples from clones 22 (4.1 units) and 25 (3.2 units) compared with clones 28 (1.5 units) and 29 (1.0 unit), but this greater relative mass was not correlated with greater cAPK activity (Fig. 3) . However, all clones had the potential to express both Type I and Type II cAPK activities.
Confocal laser scanning microscopy of immunostained filtergrown cultures demonstrated that C␣ subunit was expressed similarly in all clones and was primarily distributed throughout the cytoplasm (Fig. 6) . However, each clone had a unique cellular distribution of cAPK regulatory subunits RI␣ and RII␣ (Fig. 6) . In clones 22 and 25, RI␣ was mainly cytoplasmic. In clone 28, RI␣ was primarily near the apical surface with some punctate staining. Clone 29 RI␣ immunostaining was characterized by clear punctate staining near the apical surface with less cytoplasmic staining. In clone 22, RII␣ appeared outside of the nucleus but showed more intense staining on the apical perinuclear side of the cell layer. Clone 25 had a unique RII␣ staining pattern, with RII␣ clearly localized next to, and outside of, the nucleus. In clone 28, RII␣ immunostaining was again outside the nucleus, with more intense staining in cytoplasmic regions of the cells. Clone 29 RII␣ was cytoplasmic with some cells having more intense regions of staining, both perinuclear and cytoplasmic, than others. Therefore, although all clones had similar distributions of C subunit, there were clear clonal differences in the subcellular location of R subunits.
Clonal Phenotype Regulation by Tubular Morphogens Was
Minimal-The previous experiments showed that cysts were formed and tubular or tumor-like structures were inhibited as the cAMP pathway was activated in responsive clones. However, what mechanisms promote formation of tubular or tumorlike structures in the absence of cAMP activation? Since branching morphogenesis was studied extensively in other MDCK cells (14 -18), roles for "tubular" growth factors were investigated in the four clones. Qualitative data in a previous report (6) suggested that rhHGF could modulate process formation in clones 22 and 28 but had little effect on the spontaneous process-forming clone 25 or on clone 29. To determine if rhHGF sensitivities were responsible for differences in clonal tubule and cyst formation, gel cultures were overlaid with defined medium with a range of rhHGF concentrations (1-100 ng/ml). A modest increase in incidence of process formation (15-20%) was observed only in rhHGF-responsive clones 22 and 28 with 30 -100 ng/ml rhHGF in the presence of FBS (Fig.  7) . For most clones, in the absence of FBS or in the presence of PGE 1 , the range of rhHGF doses tested failed to induce process formation and had little effect on cyst incidence or tumor-like structure incidences (Fig. 7) . In clone 29, 10 ng/ml rhHGF was able to inhibit cyst formation induced by PGE 1 by 30 -40% (Fig.  7) . Therefore, rhHGF may modulate cyst formation in clone 29, but it seems unlikely that clonal differences in rhHGF sensitivity account for a lack of rhHGF-inducible process formation in clones 25 and 29. No change in cAMP levels was observed in response to 30 ng/ml rhHGF (data not shown). No effect of rhHGF on cAMP-mediated gene expression was observed, since luciferase activity in response to 30 ng/ml rhHGF plus IBMX (0.454 Ϯ 0.097, 0.243 Ϯ 0.169, 2.623 Ϯ 0.903, 0.052 Ϯ 0.062 for clones 22, 25, 28, and 29, respectively; n ϭ 3) was similar to activity in response to IBMX alone (Fig. 4) . Therefore, there were no apparent clonal differences in HGF stimulation of process formation in the four clones. Since HGF-mediated tubule formation was demonstrated in Type I collagen and Vitrogen (95-98% Type I, remainder Type III) gel cultures (10, 14, 18) , it is unlikely that a larger response might have been observed in the present study had a culture matrix other than Vitrogen-100® been used. Also, although the heterodimeric HGF available from the same source (R&D Systems Inc.) might have been more effective than the predominantly uncleaved single chain form used, this possibility was not evaluated since the effects of serum, which should have provided the necessary protease activity, were examined.
Epidermal growth factor acted as a cyst initiator in human kidney cells (20) and a tubular morphogen in mIMCD-3 (murine intramedullary collecting duct-3) cells (18) but not in the MDCK cells used in those reports. To determine if EGF, an activator of intracellular tyrosine kinase activity like HGF, could play a role in modulating structure in the four MDCK clones of the present study, clonal responsiveness to EGF was evaluated. In clone 22, increasing EGF concentrations prevented the formation of PGE 1 -induced cysts and maintained tumor-like structures in the presence of PGE 1 (Fig. 8) . In clones 25, 28, and 29, in the presence of 100 M IBMX or 70 nM PGE 1 plus IBMX, EGF (1-30 ng/ml) had no effect on the incidence of each type of structure formed in gel culture (data not shown). Therefore EGF and HGF may modulate three-dimensional phenotypes in some clones, but overall the effects of tyrosine kinase-mediated morphogens on the types of structures formed by these four MDCK clones were relatively modest.
Effects of tyrosine kinases on MDCK cell growth rather than structure formation were suggested by a recent report that HGF induced MDCK cell proliferation in culture on plastic or filter inserts but only after the culture reached confluence (45) . To determine if tyrosine kinase signaling could affect MDCK cell growth, the nonspecific tyrosine kinase inhibitor, genistein, was included in gel cultures for 7 days. Genistein inhibited overall clonal growth under all conditions tested (defined medium by itself, with 70 nM PGE 1 or 30 ng/ml rhHGF, or serumcontaining growth medium); however, although resulting structures were ϳ5% of the sizes seen without the inhibitor, all 3 types were present (data not shown). The concentration of genistein used was well below 350 M, the IC 50 value at which genistein might have affected protein kinase C or cAPK (46) . Therefore, the inhibitory effect of 20 M genistein universally affected clonal expansion, and its effect was exerted primarily on tyrosine kinase-mediated growth, not structure formation.
Only clone 25 consistently produced tubular structures in gel culture, and these appeared spontaneously (6) . In fact, when clone 25 was grown on filter inserts well past the point of confluence (7-9 days), tubular structures developed on the monolayer (Fig. 9) . A similar phenomenon was previously reported after long term culture of classic Type II MDCK cells on plastic (44) . In contrast, clone 29 produced spherical structures that were partially attached to the monolayer, and clones 22 and 28 remained simple monolayers (Fig. 9) . The results suggest that constitutive expression of a cellular component associated with tubule or lumen formation accounted for the apparent spontaneity of the phenotype of clone 25.
DISCUSSION
Epithelial layers of all MDCK clones used in the present study had intact intracellular cAMP pathways despite differential morphological responses to cAMP system activators in gel culture. This result demonstrated that clonal differences in morphological phenotypes were not due to diminished sensitivity to cAMP pathway agonists or a defect in cAMP signaling. Effects of tubular morphogens were modest, showing that tyrosine kinase-mediated mechanisms for morphological change were unlikely to be involved in regulating clonal phenotype. However, the cellular balance and location of Type I and Type II cAPK subtypes in each clone are predicted to differ as a result of clonal differences observed in RI␣ and RII␣ location and in relative levels of C␣ expression (Fig. 10) . Initiation of cAMP signaling could preferentially activate cAPK subtypes whose proximity to differentially expressed cellular substrates would lead to negative regulation of tubulogenesis or tumorlike structure formation and promotion of cystogenesis, depending upon the clone. These results support a mechanistic role for cAPK subtype regulation of the unique phenotypic character of each clone.
The speculation that cAPK subtypes regulate MDCK morphogenesis by providing a cAMP signal access to specific substrates at discrete subcellular locations is supported by several reports describing compartmentalization of cellular responsiveness to cAMP. Even in the present study, differences in the responsiveness of clone 25 (cAMP accumulation and gene expression) to PGE 1 and forskolin suggested cellular compartmentalization of cAMP pathway components associated with specific PGE 1 receptor-mediated signaling. Reports using clonal MDCK lines selected for PGE 1 -independence and dibutyryl cAMP-resistance (22, 23, 25) suggested that PGE 1 affected growth and differentiated function by different cAMP pathway mechanisms, including modulation of cAPK subtypes and cAMP phosphodiesterases. However, these studies did not address morphogenesis. Later reports that used either the parent MDCK line from the American Type Culture Collection or a single clonal line showed that cAMP stimulated cell proliferation, fluid secretion, and cyst formation, but that cAMP-mediated proliferation by itself was insufficient for cyst formation (10, 11) . A report that investigated the role of protein kinasemediated phosphorylation in modulation of MDCK cell tubulogenesis in gel cultures using pharmacological activators and inhibitors showed that cAPK activation promoted cyst formation and inhibited process formation in the clone used (14) . Subtypes of cAPK were not examined in these reports, but instances of cAPK subtype regulation of cellular functions have been reported more recently. For example, Type I cAPK activity was found to be higher in cancer cells than in normal or non-proliferating cells, and selective inhibition of Type I cAPK in breast cancer cells blocked mitogenesis (reviewed in Ref. 47) . A clear role for a cAPK subtype was demonstrated by the report that a unique AKAP (A-kinase anchoring protein) was responsible for presenting Type II cAPK and protein phosphatase-1 to a specific substrate, the N-methyl-D-aspartate receptor, whose ion channel activity was regulated by phosphorylation (48) . Therefore, compartmentalization of cAMP responsiveness resulting in a range of functional outcomes has been demonstrated and may result from cAPK subtype expression.
MDCK diversity in the intracellular cAMP signals available to activate cAPK subtypes was demonstrated by clonal differences in cAMP accumulation in response to extracellular agonists. This could reflect the action of subsets of phosphodiesterase activities in each clone, since IBMX will not inhibit all subtypes, and forskolin was expected to activate a larger proportion of the available adenylyl cyclase of the cell than PGE 1 would acting through a receptor-specific mechanism. Clonal diversity in substrates available to mediate cAPK action can be speculated upon, although at this point, the evidence that each clone exhibited a unique pattern of cAPK subunit localization suggests that subcellular co-localization of a cAPK subtype with a universally expressed substrate is equally likely. However, specific cAPK substrates or genes affected as cysts form and other structures are lost in the four clones are presently unknown. In clone 28, cAMP and cAPK were unlikely to have stimulated the fluid secretion required for cyst expansion, since structures were characteristic of those in which cAMP-mediated fluid secretion was blocked and uncoupled from cell proliferation (10) . However, the magnitude of clone 28 cAPKmediated gene expression response suggested that components of this pathway were very sensitive to agonists or were localized near the site of cAMP synthesis, compared with those in other clones. In clone 29, cyst formation was unrelated to cAPK-mediated gene expression and probably involved more direct actions on cellular enzyme activities or channels that lead to fluid transport. The existence of these clonal differences supports the hypothesis that mechanisms at (subtypes) and/or downstream of (specific gene targets, cellular enzyme activities, or ion channels and fluid transport) cAPK were responsible for phenotypic differences observed. Intracellular variability in the cellular balance between the two cAPK subtypes along with the clear clonal differences in subcellular distribution could be the basis for preferential modulation of substrates.
For example, the cellular component responsible for the spontaneous tubule formation of clone 25 under a variety of conditions must be subject to cAMP-mediated regulation since activation of the cAMP pathway downregulated the incidence of tubular processes as the incidence of cystic structures rose. Several cellular proteins, growth factors, and receptors have been reported to be associated with tubulogenesis (reviewed in Refs. 2, 49, and 50) . A previous report demonstrated that specifically localized ␤-catenins were involved in the development of tubular processes from an initial cystic structure of MDCK cells (19) . Perhaps the specific location of cAPK subtypes in clone 25 allowed a cellular modulator access to a protein complex involved in control of the developing tubular process.
The developmental renal disease family of inherited PKDs is characterized by progressive enlargement of nephrons to form many fluid-filled cysts. Researchers have hypothesized that protein products of the three known PKD genes (polycystin-1, polycystin-2, and the Tg737 gene product are components of a membrane-associated signaling complex involved in nephrogenesis and that mutations contribute to the pathogenesis of PKD by altering the function of the complex (reviewed in Refs. 51 and 52). Polycystin-1 was found to be a cAPK substrate (53, 54) . Genetic studies showed that in addition to the three known genes, several other independent chromosomal loci were linked to the phenotypic expression of PKD (reviewed in Ref. in human autosomal recessive PKD, 2 cAPK subunit localization differences in cells derived from cystic kidneys of murine models of PKD, and abnormal cell proliferation possibly due to cAMP/EGF receptor interactions that did not occur in noncystic cells. 3 If a PKD protein complex is involved in regulating normal nephrogenesis, then mutations that altered its interaction with, or regulation by, cAPK subtypes could contribute to cyst formation. In summary, intracellular diversity in the cellular complement of Type I and Type II cAPK activities, their subcellular locations, and their preferred targets is likely to account for the ability of cAPK to regulate the complicated process of MDCK morphogenesis. These results are potentially important with respect to the functional significance of mechanisms that regulate subcellular location of cAPK subunits and may be relevant to renal development and disease.
